These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33579840)

  • 1. TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death.
    Buciuc M; Tosakulwong N; Machulda MM; Whitwell JL; Weigand SD; Murray ME; Reichard RR; Parisi JE; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Josephs KA
    J Alzheimers Dis; 2021; 80(2):683-693. PubMed ID: 33579840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.
    Buciuc M; Wennberg AM; Weigand SD; Murray ME; Senjem ML; Spychalla AJ; Boeve BF; Knopman DS; Jack CR; Kantarci K; Parisi JE; Dickson DW; Petersen RC; Whitwell JL; Josephs KA
    J Alzheimers Dis; 2020; 73(4):1511-1523. PubMed ID: 31929165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease.
    Buciuc M; Whitwell JL; Boeve BF; Ferman TJ; Graff-Radford J; Savica R; Kantarci K; Fields JA; Knopman DS; Petersen RC; Parisi JE; Murray ME; Dickson DW; Josephs KA
    J Neurol; 2020 May; 267(5):1444-1453. PubMed ID: 32006160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 pathology, cognitive decline, and dementia in old age.
    Wilson RS; Yu L; Trojanowski JQ; Chen EY; Boyle PA; Bennett DA; Schneider JA
    JAMA Neurol; 2013 Nov; 70(11):1418-24. PubMed ID: 24080705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline.
    Chang K; Ling JP; Redding-Ochoa J; An Y; Li L; Dean SA; Blanchard TG; Pylyukh T; Barrett A; Irwin KE; Moghekar A; Resnick SM; Wong PC; Troncoso JC
    Acta Neuropathol; 2023 Dec; 147(1):4. PubMed ID: 38133681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
    Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
    Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
    Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults.
    Karanth S; Nelson PT; Katsumata Y; Kryscio RJ; Schmitt FA; Fardo DW; Cykowski MD; Jicha GA; Van Eldik LJ; Abner EL
    JAMA Neurol; 2020 Oct; 77(10):1299-1307. PubMed ID: 32568358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
    James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
    Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying Neuropathologies.
    Karanth SD; Schmitt FA; Nelson PT; Katsumata Y; Kryscio RJ; Fardo DW; Harp JP; Abner EL
    J Alzheimers Dis; 2021; 82(2):647-659. PubMed ID: 34057090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
    Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
    Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis.
    Gauthreaux KM; Teylan MA; Katsumata Y; Mock C; Culhane JE; Chen YC; Chan KCG; Fardo DW; Dugan AJ; Cykowski MD; Jicha GA; Kukull WA; Nelson PT
    Neurology; 2022 Apr; 98(14):e1422-e1433. PubMed ID: 35121671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).
    Josephs KA; Murray ME; Tosakulwong N; Whitwell JL; Knopman DS; Machulda MM; Weigand SD; Boeve BF; Kantarci K; Petrucelli L; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Dickson DW
    Acta Neuropathol; 2017 May; 133(5):705-715. PubMed ID: 28160067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between hippocampal microglia, AD and LATE-NC, and cognitive decline in older adults.
    Kapasi A; Yu L; Leurgans SE; Agrawal S; Boyle PA; Bennett DA; Schneider JA
    Alzheimers Dement; 2024 May; 20(5):3193-3202. PubMed ID: 38494787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults.
    Makkinejad N; Schneider JA; Yu J; Leurgans SE; Kotrotsou A; Evia AM; Bennett DA; Arfanakis K
    Neurobiol Aging; 2019 May; 77():104-111. PubMed ID: 30784812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.
    Tremblay C; François A; Delay C; Freland L; Vandal M; Bennett DA; Calon F
    J Neuropathol Exp Neurol; 2017 Feb; 76(2):70-88. PubMed ID: 28158844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
    Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.
    Malek-Ahmadi M; Perez SE; Chen K; Mufson EJ
    J Alzheimers Dis; 2020; 74(1):189-197. PubMed ID: 31985469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
    Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
    Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.